Amrize Ltd AMRZ
- Market cap
- $20.5B
- P/E
- 17.5×
Follow AMRZ
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | 44.12 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | — | — | 56.76 |
High Price
|
|||
| — | — | — | — | — | — | — | — | 19,000 | 19,000 |
Employees
|
|||
| — | — | — | — | — | — | — | 0 | 1 | 1 |
Revenue/Emp
|
|||
| — | — | — | — | — | — | — | 11,677 | 11,704 | 11,815 |
Revenue
|
|||
| — | — | — | — | — | — | — | 23.71% | 26.23% | 25.68% |
Gross Margin
|
|||
| — | — | — | — | — | — | — | 1,303 | 1,628 | 1,497 |
EBT
|
|||
| — | — | — | — | — | — | — | 11.16% | 13.91% | 12.67% |
EBT Margin
|
|||
| — | — | — | — | — | — | — | 955 | 1,273 | 1,182 |
Net Income
|
|||
| — | — | — | — | — | — | — | 852 | 889 | 914 |
Depreciation
|
|||
| — | — | — | — | — | — | — | 0.00 | 21.16 | 21.36 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | — | — | 2.30 | 2.14 |
Earnings/Sh
|
|||
| — | — | — | — | — | — | — | 0.00 | 4.13 | 3.99 |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | — | 0.00 | (0.99) | (1.35) |
Capex/Sh
|
|||
| — | — | — | — | — | — | — | 0.00 | 3.13 | 2.64 |
Free CF/Sh
|
|||
| — | — | — | — | — | — | — | 0.00 | 17.92 | 23.96 |
Book Value/Sh
|
|||
| — | — | — | — | — | — | — | — | 553 | 553 |
Shares
|
|||
| — | — | — | — | — | — | — | 20.01 | 20.01 | 25.12 |
PE Ratio
|
|||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 2.53 |
PS Ratio
|
|||
| — | — | — | — | — | — | — | 2.90 | 2.90 | 2.28 |
PB Ratio
|
|||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 2.82 |
EV/Sales
|
|||
| — | — | — | — | — | — | — | 42.34 | 42.34 | 22.76 |
EV/FCF
|
|||
| — | — | — | — | — | — | — | 2,036 | 2,282 | 2,208 |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | — | (581) | (549) | (747) |
Capex
|
|||
| — | — | — | — | — | — | — | 1,455 | 1,733 | 1,461 |
FCF
|
|||
| — | — | — | — | — | — | — | 1,496 | 2,231 | 1,824 |
Working Cap'
|
|||
| — | — | — | — | — | — | — | 1,107 | 1,114 | 5,269 |
Total Debt
|
|||
| — | — | — | — | — | — | — | 0 | (471) | 3,347 |
Net Debt
|
|||
| — | — | — | — | — | — | — | 9,203 | 9,914 | 13,254 |
Sh' Equity
|
|||
| — | — | — | — | — | — | — | 0.00% | 5.44% | 4.93% |
ROA
|
|||
| — | — | — | — | — | — | — | 12.71% | 14.07% | 7.18% |
ROIC
|
|||
| — | — | — | — | — | — | — | 0.00% | 13.33% | 10.23% |
ROE
|
|||
Amrize Ltd peers in Building Materials
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| JHX James Hardie Industries PLC. | $15.2B | 104× | Compare |
| CX Cemex S.A.B. de C.V. | $14.5B | 27.7× | Compare |
| VMC Vulcan Materials Company | $31.3B | 28.8× | Compare |
| MLM Martin Marietta Materials, Inc. | $34.1B | 11.9× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| CRH CRH PLC | $58.8B | 14.9× | Compare |
| EXP Eagle Materials Inc | $5.4B | 14.1× | Compare |
| USLM United States Lime & Minerals, Inc. | $3.1B | 23.8× | Compare |
| KNF Knife River Corporation | $3.0B | 22.1× | Compare |
Amrize Ltd (AMRZ) key facts
- Amrize Ltd (AMRZ) is a Building Materials company in the Basic Materials sector, listed on the New York Stock Exchange.
- Amrize Ltd’s revenue for fiscal 2025 (year ended December 2025) was $11.8 billion, up 0.95% from fiscal 2024.
- Net income was $1.2 billion, or $2.14 per share (basic), a net margin of 10.0%.
- As of September 25, 2026, AMRZ traded at $38.22, a market capitalization of $20.5 billion.
- At that price the stock trades at 17.5× trailing-twelve-month earnings and 1.7× sales.
- Return on equity was 10.2% and debt-to-equity 0.47.
Amrize Ltd (AMRZ) Latest News
22 Sep
UBS expects Amrize Ltd's 2027 outlook to improve after a weak 2026, with earnings growth returning toward the mid-teens. The upgrade signals renewed investor optimism about the company's trajectory, though details on catalysts and timing are not provided in the headline. Positive sentiment shift from UBS could influence near-term expectations but lacks corroborating detail in the brief headline.
17 Sep
Leadership changes at Amrize Ltd test its turnaround story and raise questions on whether AMRZ shares are undervalued. Leadership transitions introduce uncertainty around Amrize turnaround execution and valuation outlook.
13 Aug
Amrize Ltd (AMRZ) released its Q2 2026 earnings call transcript covering financial results, operational updates, and forward guidance. Standard earnings disclosure provides moderate updates on performance and outlook that may influence near-term sentiment.
10 Aug
Amrize Ltd missed Q2 earnings and cut EBITDA guidance, prompting RBC Capital Markets to flag execution concerns. Q2 earnings miss combined with lowered EBITDA guidance signals material execution risks that are likely to weigh on stock performance and sentiment.
7 Aug
Amrize Ltd posted strong Q2 2026 revenue growth and raised full-year guidance. Raised guidance after strong revenue growth signals improved financial outlook and performance trajectory for Amrize Ltd.
Amrize Ltd (AMRZ) shares declined in extended trading after missing Q2 profit estimates and cutting full-year EBITDA guidance. Q2 profit miss and reduced EBITDA guidance directly lower earnings expectations and pressure valuation.
Amrize Ltd presented Q2 earnings call highlights covering financial results and outlook. Q2 earnings updates can moderately influence short-term financial sentiment and operations.
Amrize Ltd posted strong Q2 2026 revenue growth despite cost headwinds. Mixed revenue gains and cost pressures indicate moderate influence on future performance.
Amrize Ltd held its Q2 2026 earnings call covering financial results and outlook. Q2 earnings details can moderately shift views on financial performance and strategy.
6 Aug
Amrize Ltd (AMRZ) released Q2 earnings results with focus on key financial metrics. Q2 earnings and associated metrics can moderately shift near-term investor sentiment and stock movement.
Amrize Ltd (AMRZ) missed Q2 earnings estimates. Quarterly earnings misses typically trigger moderate negative stock reactions and revised near-term forecasts.
Amrize Ltd reported second quarter 2026 financial results. Quarterly results release key metrics that shape short-term investor views on performance.
20 Jul
Amrize Ltd acquires Rapid Redi-Mix in Dallas-Fort Worth. Acquisition expands Amrize operations in Dallas-Fort Worth market.
12 Jul
Amrize Ltd breaks ground on modernization project at Saint-Constant Cement Plant. Plant modernization at single site supports efficiency gains with limited scope for company-wide trajectory shift.
19 Jun
Amrize will modernize its Montreal area cement plant to become the most advanced facility in Eastern Canada. Single-plant upgrade improves regional production capacity and efficiency without transforming overall company trajectory.
18 Jun
Amrize Ltd held groundbreaking ceremony for modernization of Saint-Constant Cement Plant. Modernization targets core production facility with potential to lift efficiency and capacity.
5 May
Amrize Ltd (AMRZ) launches a $1 billion share buyback program. $1 billion share buyback signals strong financial confidence and boosts EPS, significantly impacting stock performance.
2 May
Analysts are updating their estimates for Amrize AG (VTX:AMRZ) following the company's first-quarter results. Analyst estimate updates after Q1 results can moderately influence financial performance expectations and investor sentiment.
1 May
Amrize Ltd (AMRZ) reported strong revenue growth in Q1 2026 earnings call despite facing challenges. Strong revenue growth in Q1 2026 signals significant positive impact on AMRZ's financial performance and investor sentiment despite challenges.
Amrize Ltd (AMRZ) Q1 earnings call highlights key quarterly financial results, operational updates, management commentary, and forward-looking guidance. Q1 earnings call highlights reveal quarterly performance metrics and outlook with moderately noticeable influence on financials and investor sentiment.
30 Apr
Amrize Ltd (AMRZ) identified as one of the best IPO stocks to buy in 2026. Designation as top IPO stock expected to moderately boost investor sentiment and short-term market interest without fundamentally altering core trajectory.
29 Apr
Amrize Ltd (AMRZ) released Q1 earnings, analyzing key metrics for insights into financial health and performance. Q1 earnings reports reveal core financial metrics that significantly shape investor sentiment and stock trajectory.
Amrize Ltd (AMRZ) reported 4.7% revenue growth in the first quarter and reaffirmed its 2026 guidance. Q1 revenue increased 4.7% with reaffirmed 2026 guidance, signaling moderate financial stability without major shifts.
20 Apr
Amrize Ltd (AMRZ) expected to potentially beat earnings estimates again in upcoming report after prior successes. Earnings beat speculation can moderately sway financial performance expectations and investor sentiment.
15 Apr
Amrize Ltd expands its ‘Made in America’ label to nine U.S. cement plants, enhancing domestic production branding. Expanding ‘Made in America’ labeling to nine plants represents a major strategic branding move boosting market appeal and competitive positioning.
5 Apr
Amrize Ltd (AMRZ) appoints new CFO, spotlighting valuation and capital decisions. New CFO appointment targets core financial strategy areas like valuation and capital allocation, with moderate expected influence on performance.
31 Mar
Amrize Ltd (AMRZ) appoints Baris Oran as its new Chief Financial Officer. CFO appointment influences financial strategy, reporting, and investor sentiment moderately.
Amrize Ltd (AMRZ) receives Buy rating from analysts due to strong cement margins. Buy rating on strong cement margins signals moderately positive financial outlook and investor sentiment.
14 Mar
Amrize Ltd (AMRZ) launches EVERtect, a new high-performance concrete product line designed for superior durability and efficiency in construction applications. Launching a new high-performance concrete product line constitutes a major strategic initiative likely to strengthen competitive positioning and drive revenue growth.
13 Mar
JPMorgan raised its price target on Amrize Ltd (AMRZ) while maintaining a Buy rating. JPMorgan's price target increase and Buy rating maintenance signal strong analyst confidence, likely driving significant positive investor sentiment and stock performance.